SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2'deoxycytidine to increase SPARC expression and improve therapy response.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples